Shulan Tian
Overview
Explore the profile of Shulan Tian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
8701
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Guo G, Gong K, Beckley N, Zhang Y, Yang X, Chkheidze R, et al.
Nat Cell Biol
. 2022 Aug;
24(8):1291-1305.
PMID: 35915159
The epidermal growth factor receptor (EGFR) is a prime oncogene that is frequently amplified in glioblastomas. Here we demonstrate a new tumour-suppressive function of EGFR in EGFR-amplified glioblastomas regulated by...
12.
Gagnon M, Tian S, Geyer S, Sharma N, Vachon C, Kusne Y, et al.
Blood Cancer J
. 2022 Jul;
12(7):112.
PMID: 35882836
No abstract available.
13.
Tian S, Tu Z, Yan H, Klee E
Front Genet
. 2022 Apr;
13:896032.
PMID: 35432455
No abstract available.
14.
Mladek A, Yan H, Tian S, Decker P, Burgenske D, Bakken K, et al.
Neuro Oncol
. 2022 Mar;
24(8):1261-1272.
PMID: 35231103
Background: RBBP4 activates transcription by histone acetylation, but the partner histone acetyltransferases are unknown. Thus, we investigated the hypothesis that RBBP4 interacts with p300 in a complex in glioblastoma (GBM)....
15.
Pottier C, Mateiu L, Baker M, DeJesus-Hernandez M, Teixeira Vicente C, Finch N, et al.
Brain
. 2021 Dec;
145(7):2472-2485.
PMID: 34918030
Frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) is a complex heterogeneous neurodegenerative disorder for which mechanisms are poorly understood. To explore transcriptional changes underlying FTLD-TDP, we performed RNA-sequencing on 66...
16.
Differential transcriptomic profiling in ibrutinib-naïve versus ibrutinib-resistant Richter syndrome
Wang H, Tian S, Zhao Q, Blumenschein W, Yearley J, Secreto C, et al.
Hematol Oncol
. 2021 Nov;
40(2):302-306.
PMID: 34806797
No abstract available.
17.
Marin B, Porath K, Jain S, Kim M, Conage-Pough J, Oh J, et al.
Neuro Oncol
. 2021 May;
23(12):2042-2053.
PMID: 34050676
Background: Antibody drug conjugates (ADCs) targeting the epidermal growth factor receptor (EGFR), such as depatuxizumab mafodotin (Depatux-M), is a promising therapeutic strategy for glioblastoma (GBM) but recent clinical trials did...
18.
Tian S, Zhang H, Zhang P, Kalmbach M, Lee J, Ordog T, et al.
Sci Rep
. 2021 Apr;
11(1):8318.
PMID: 33859327
T cell prolymphocytic leukemia (T-PLL) is a rare disease with aggressive clinical course. Cytogenetic analysis, whole-exome and whole-genome sequencing have identified primary structural alterations in T-PLL, including inversion, translocation and...
19.
Cutrer F, Moyer A, Atkinson E, Wang L, Tian S, Wu Y, et al.
Mol Genet Genomic Med
. 2021 Apr;
9(6):e1680.
PMID: 33829662
Background: Currently, there is no biologically based rationale for drug selection in migraine prophylactic treatment. Methods: To investigate the genetic variation underlying treatment response to verapamil prophylaxis, we selected 225...
20.
Yan H, Tian S, Kleinstern G, Wang Z, Lee J, Boddicker N, et al.
Hum Mol Genet
. 2020 Aug;
29(16):2761-2774.
PMID: 32744316
Chronic lymphocytic leukemia (CLL) is the most common adult leukemia in Western countries. It has a strong genetic basis, showing a ~ 8-fold increased risk of CLL in first-degree relatives....